A 59-Year-Old Female With Lung Cancer

Expert oncologist Zofia Piotrowska, MD, reviews the case of a 59-year-old woman who is diagnosed and treated for EGFR exon 20–positive non–small cell lung cancer.

EP. 1: Expert Perspectives on a Case of Stage 4 NSCLC

April 26th 2022

Expert oncologist Zofia Piotrowska, MD, reviews the case of a patient managed with frontline chemotherapy after receiving a diagnosis of stage 4 NSCLC.

EP. 2: Novel Targeted Therapy for EGFR Exon 20–Positive NSCLC

April 26th 2022

Comprehensive insight on the two novel, targeted agents approved for the management of EGFR exon 20–positive NSCLC following frontline therapy.

EP. 3: Real-World Use of Targeted Agents in EGFR Exon 20–Positive NSCLC

April 26th 2022

Practical advice regarding the selection and management of amivantamab or mobocertinib in patients diagnosed with EGFR exon 20–positive NSCLC.

EP. 4: EGFR Exon 20–Positive NSCLC: Future Directions in Care

April 26th 2022

Before closing out her discussion on novel therapy for EGFR exon 20–positive NSCLC, Zofia Piotrowska, MD, shares her hopes for future developments in care.